A influência mútua entre o tratamento do câncer de mama e os transtornos mentais em pacientes idosas

##plugins.themes.bootstrap3.article.main##

Esther Teófilo Rosemberg
Luísa Mendes Batista Pereira
Raíssa Gontijo Jales
Vitória Tokarski Bley
Mariana Freitas Machado Naves
Pedro Henrique Simões de Lima Assis
Gabriel Pires Fernandes
Renata Aparecida Elias Dantas

Resumo

Objetivo: Analisar a influência mútua entre o tratamento do câncer de mama e os transtornos mentais em pacientes idosas. Métodos: Trata-se de uma revisão integrativa, na qual foram selecionados nas bases de dados PubMed, Scopus e BVS, artigos científicos publicados nos últimos cinco anos, utilizando os descritores “aged women”, “treatment”, “breast cancer” e “mental disorders”. A busca integrativa criteriosa resultou em 1400 artigos.  Após a aplicação dos critérios de elegibilidade, foram incluídos 20 estudos. Resultados: Os artigos encontrados foram divididos em dois grupos: no primeiro grupo foi avaliado aumento na prevalência de depressão e ansiedade e impacto negativo na função cognitiva em pacientes em tratamento de câncer de mama; já no segundo grupo, os transtornos mentais tiveram associação com o aumento da mortalidade por câncer de mama e piores desfechos da doença (aumento do tempo de hospitalização e risco de infecções pós-cirúrgicas), sendo averiguada associação de fármacos psiquiátricos com aumento do risco de surgimento de câncer de mama. Considerações finais: É evidente a influência mútua entre o tratamento de câncer de mama e os transtornos mentais em pacientes idosas, de forma geral apresentando impactos bilateralmente negativos.

##plugins.themes.bootstrap3.article.details##

Como Citar
RosembergE. T., PereiraL. M. B., JalesR. G., BleyV. T., NavesM. F. M., AssisP. H. S. de L., FernandesG. P., & DantasR. A. E. (2024). A influência mútua entre o tratamento do câncer de mama e os transtornos mentais em pacientes idosas. Revista Eletrônica Acervo Médico, 24, e15244. https://doi.org/10.25248/reamed.e15244.2024
Seção
Artigos Originais

Referências

1. AHLGRÉN-RIMPILÄINEN AJ, et al. Excess mortality from breast cancer in female breast cancer patients with severe mental illness. Psychiatry research, 2020; 286; 112801: 112801.

2. ÁLVAREZ-PARDO S, et al. Related factors with depression and anxiety in mastectomized women breast cancer survivors. International journal of environmental research and public health, 2023; 20: 4.

3. BEDILLION MF, et al. A Cancer treatment effects on cognition and depression: The moderating role of physical activity. Breast (Edinburgh, Scotland), 2019; 44: 73–80.

4. BLANCHETTE PS, et al. The association between endocrine therapy use and dementia among post-menopausal women treated for early-stage breast cancer in Ontario, Canada. Journal of geriatric oncology, 2020; 11; 7: 1132–1137.

5. BREIDENBACH C, et al. Prevalence and determinants of anxiety and depression in long-term breast cancer survivors. BMC psychiatry, 2022; 22; 1: 101.

6. BUSCARIOLLO DL, et al. Impact of pre-diagnosis depressive symptoms and health-related quality of life on treatment choice for ductal carcinoma in situ and stage I breast cancer in older women. Breast Cancer Research and Treatment, 2018; 173: 709-717.

7. CARREIRA H, et al. Associations between breast cancer survivorship and adverse mental health outcomes: A matched population-based cohort study in the United Kingdom. PLoS medicine, 2021; 18: 1003504.

8. CHU RYK, et al. Breast cancer risks following antipsychotic use in women with bipolar disorder versus schizophrenia: A territory-wide nested case-control study spanning two decades. Psychiatry research, 2023; 326: 115287.

9. DALTON SO, et al. Impact of schizophrenia and related disorders on mortality from breast cancer: A population-based cohort study in Denmark, 1995-2011. Breast (Edinburgh, Scotland), 2018; 40: 170–176.

10. DESHPANDE AJ, et al. Examining the relationship between severe persistent mental illness and surgical outcomes in women undergoing mastectomy for breast cancer. American journal of surgery, 2023; 226; 1: 4–10.

11. FOND G, et al. End of life breast cancer care in women with severe mental illnesses. Scientific reports, 2021;11: 10167.

12. GUIMOND A-J, et al. Clusters of psychological symptoms in breast cancer: Is there a common psychological mechanism? Cancer nursing, 2020; 43: 343–353.

13. HASKINS CB, et al. Impact of preexisting mental illness on breast cancer endocrine therapy adherence. Breast cancer research and treatment, 2019; 174: 197–20

14. HASKINS CB, et al. Effects of previous medication regimen factors and bipolar and psychotic disorders on breast cancer endocrine therapy adherence. Clinical breast cancer, 2020; 20 e261–e280.

15. HORMOZI M, et al. Investigating relationship between pre- and post- chemotherapy cognitive performance with levels of depression and anxiety in breast cancer patients: A cross-sectional study. Asian Pacific journal of cancer prevention: APJCP, 2019; 20: 3831–3837

16. JOMAR RT, et al. Fatores associados ao tempo para submissão ao primeiro tratamento do câncer de mama. Ciência & Saúde Coletiva, 2023; 28: 2155–2164.

17. LEAL FR, et al. Prevalência de depressão e ansiedade e sua relação com esperança em pacientes oncológicos em tratamento quimioterápico. rmmg.org, 2021; 31: 61–66.

18. MARTIN C, et al. Treatment choices for older women with primary operable breast cancer and cognitive impairment: Results from a prospective, multicentre cohort study. Journal of geriatric oncology, 2021; 12; 5: 705–713.

19. MARTIN C, et al. Caregiver experiences of making treatment decisions for older women with breast cancer and dementia. Health & social care in the community, 2022; 30; 5: e2058–e2068.

20. MONTILLA D, et al. Mortalidade por câncer de mama em mulheres idosas no Brasil e nas grandes regiões: uso do SISAP-Idoso. Reciis, 2023; 17: 372–386.

21. PIROTH MD, et al. Anxiety and depression in patients with breast cancer undergoing radiotherapy: the role of intelligence, life history, and social support-preliminary results from a monocentric analysis. Strahlentherapie Und Onkologie: Organ Der Deutschen Rontgengesellschaft. 2022; 198; 4; 388–396.

22. SHEN Q, et al. Psychiatric disorders and cardiovascular diseases during the diagnostic workup of potential breast cancer: a population-based cohort study in Skåne, Sweden. Breast cancer research: BCR, 2019; 21: 139.

23. TAIPALE H, et al. Antipsychotic use and risk of breast cancer in women with schizophrenia: a nationwide nested case-control study in Finland. The lancet. Psychiatry, 2021; 8: 883–891.